In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant.
Heinen N, Marheinecke CS, Bessen C, Blazquez-Navarro A, Roch T, Stervbo U, Anft M, Plaza-Sirvent C, Busse S, Klöhn M, Schrader J, Vidal Blanco E, Urlaub D, Watzl C, Hoffmann M, Pöhlmann S, Tenbusch M, Steinmann E, Todt D, Hagenbeck C, Zimmer G, Schmidt WE, Quast DR, Babel N, Schmitz I, Pfänder S.
Heinen N, et al. Among authors: schmitz i.
Front Immunol. 2022 Dec 21;13:1062210. doi: 10.3389/fimmu.2022.1062210. eCollection 2022.
Front Immunol. 2022.
PMID: 36618413
Free PMC article.